Health Economics Course 2024 (16/09/2024 – 31/10/2024)

 Please stay tuned, the EHC will announce the registration for the 2024 edition on its website and social media channels. 

For a decade the EHC has provided NMOs and a wider community with education on the evolution of health economics, tender process, and procurement in bleeding disorders. 

From the first face-to-face meeting in London in 2013, health technology assessments (HTA) have become commonplace in national healthcare systems and bleeding disorders.  The ability for an individual patient to input into horizon scanning, model inputs and design, procurement methods, and reporting is increasing with HTA agencies improving their engagement processes. The EHC aims to ensure access to education for patients and patient organisations on-demand for engaging in health technology assessments. As a result, in 2023, the EHC decided to create an online educational course on Health Economics in Europe.

We invite all rare bleeding disorders patients to enrol in this course. The programme may also act as a quick reference guide for students, researchers, and HTA agencies to begin to understand the issues related to bleeding disorders and how to evaluate them. Please note that pharma companies’ representatives will not be accepted as attendees. 

The programme of this course is held online, consisting of sequential webinars (for self-education) with additional interactive materials to improve personal and NMO knowledge. 

Programme (subject to a review):

Module 1 – Introduction to Health Economics
 
Module 2 – Health Technology Assessments (HTA) – Understanding Outcomes
 
Module 3 – Cost-Effectiveness and Budget Impact Models in Bleeding Disorders
 
Module 4 – Payment Models


For any questions, please contact us at education@ehc.eu.

The EHC thanks the sponsors for their continuous support of this project.

* This educational course is for educational purposes only, does not endorse or promote any specific pharmaceutical organisation, drug or other medical intervention, and has been developed, created, and delivered by the EHC in collaboration with Prime HCD experts independently from sponsors of this project.